Precancerous colorectal lesions occurring in patients with inflammatory bowel disease (IBD) are now described as either polypoid, nonpolypoid, or invisible. Patients diagnosed with colonic IBD should ...

The oral cavity may be involved (ie, with ulcers), but the esophagus and pharynx are rarely involved. The antrum and duodenum are the most common sites involved in the upper gastrointestinal tract.

Inflammatory bowel disease (IBD) may have a "substantial symptomatic period" before clinical diagnosis. Symptoms of IBD—abdominal pain, diarrhea, rectal bleeding—may show up 10 years or more before ...

Managing inflammatory bowel disease (IBD) in pregnancy is uniquely complex. Because pregnant patients are typically excluded from clinical trials with experimental treatments, data on newer therapies ...

Please provide your email address to receive an email when new articles are posted on . Artificial intelligence has been used extensively in gastroenterology for polyp detection and is expanding into ...

Researchers from Nashville, Tenn.-based Vanderbilt University created an endoscope that uses Raman spectroscopy, a chemical-fingerprinting technique, to detect inflammatory bowel disease in the colon.

Inflammatory Bowel Disease (IBD) is a long-term condition that causes ulcers and swelling in the digestive tract.

In two journal articles, a University of Houston biomedical researcher reports a step forward in diagnosing intestinal diseases, including colorectal cancer, ulcerative colitis and Crohn's disease ...

A fecal lactoferrin test can detect intestinal inflammation. High lactoferrin levels in stool suggest that inflammation is present. This may indicate a bacterial infection or inflammatory bowel ...

Patients with inflammatory bowel disease and precancerous colorectal lesions face an increased risk of developing colorectal cancer, with risk levels tied to the severity of the lesions, according to ...

Up to 3.1 million people live with inflammatory bowel disease (IBD), which includes gastrointestinal disorders such as ulcerative colitis (UC) and Crohn’s disease that cause inflammation in the ...

NImmune Biopharma ("NImmune"), a private late-stage precision inflammation and immunology ("I&I") biopharmaceutical company, today announced that Executive Chairman, President and CEO Dr. Josep ...